Persistence of Immune Response in Health Care Workers After Two Doses BNT162b2 in a Longitudinal Observational Study

BACKGROUND: The mRNA-based vaccine BNT162b2 of BioNTech/Pfizer has shown high efficacy against SARS-CoV-2 infection and a severe course of the COVID-19 disease. However, little is known about the long-term durability of the induced immune response resulting from the vaccination. METHODS: In a longit...

Descripción completa

Detalles Bibliográficos
Autores principales: Herzberg, Jonas, Fischer, Bastian, Lindenkamp, Christopher, Becher, Heiko, Becker, Ann-Kristin, Honarpisheh, Human, Guraya, Salman Yousuf, Strate, Tim, Knabbe, Cornelius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931311/
https://www.ncbi.nlm.nih.gov/pubmed/35309303
http://dx.doi.org/10.3389/fimmu.2022.839922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931311/
https://www.ncbi.nlm.nih.gov/pubmed/35309303
http://dx.doi.org/10.3389/fimmu.2022.839922

Ejemplares similares